Group One Trading’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-45,300
| Closed | -$1.08M | – | 8862 |
|
|
2021
Q1 | $1.08M | Sell |
45,300
-1,600
| -3% | -$29.7K | ﹤0.01% | 3135 |
|
|
2020
Q4 | $685K | Sell |
46,900
-1,900
| -4% | -$25.2K | ﹤0.01% | 2994 |
|
|
2020
Q3 | $693K | Buy |
48,800
+28,000
| +135% | +$428K | ﹤0.01% | 2553 |
|
|
2020
Q2 | $306K | Sell |
20,800
-500
| -2% | -$5.08K | ﹤0.01% | 3031 |
|
|
2020
Q1 | $88K | Buy |
+21,300
| New | +$99.9K | ﹤0.01% | 3391 |
|
|
2015
Q4 | – | Sell |
-5,000
| Closed | -$39K | – | 5278 |
|
|
2015
Q3 | $39K | Hold |
5,000
| – | – | ﹤0.01% | 3686 |
|
|
2015
Q2 | $45K | Hold |
5,000
| – | – | ﹤0.01% | 3612 |
|
|
2015
Q1 | $65K | Buy |
+5,000
| New | +$65.4K | ﹤0.01% | 3205 |
|
|
2014
Q1 | – | Sell |
-800
| Closed | -$11K | – | 5725 |
|
|
2013
Q4 | $11K | Sell |
800
-1,300
| -62% | -$15.8K | ﹤0.01% | 4556 |
|
|
2013
Q3 | $26K | Sell |
2,100
-4,000
| -66% | -$42.9K | ﹤0.01% | 4012 |
|
|
2013
Q2 | $63K | Buy |
+6,100
| New | +$84.1K | ﹤0.01% | 3231 |
|
Group One Trading's GNMK Position: Q2 2021 in Review
Group One Trading sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,288 shares — an estimated $31K sold.
Group One Trading first reported a position in GNMK in Q2 2013 and held it in 8 quarters. The position peaked at $307K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Group One Trading reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Group One Trading sold 1,288 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $31K.
- Group One Trading first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 8 quarters.
- Group One Trading's GenMark Diagnostics, Inc position peaked at $307K in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.